Abstract: The present invention relates to a compound of general formula (I) or a pharmaceutically acceptable salt and/or solvate thereof. The invention further relates to the use of the compounds of the invention as neuroprotective and/or neurorestorative agents, in particular for use in the treatment of neurological disorders.
| # | Name | Date |
|---|---|---|
| 1 | 202517005166-STATEMENT OF UNDERTAKING (FORM 3) [22-01-2025(online)].pdf | 2025-01-22 |
| 3 | 202517005166-Sequence Listing in PDF [22-01-2025(online)].pdf | 2025-01-22 |
| 4 | 202517005166-REQUEST FOR EXAMINATION (FORM-18) [22-01-2025(online)].pdf | 2025-01-22 |
| 5 | 202517005166-FORM 18 [22-01-2025(online)].pdf | 2025-01-22 |
| 6 | 202517005166-FORM 1 [22-01-2025(online)].pdf | 2025-01-22 |
| 7 | 202517005166-DECLARATION OF INVENTORSHIP (FORM 5) [22-01-2025(online)].pdf | 2025-01-22 |
| 8 | 202517005166-COMPLETE SPECIFICATION [22-01-2025(online)].pdf | 2025-01-22 |
| 9 | 202517005166-Proof of Right [19-04-2025(online)].pdf | 2025-04-19 |
| 10 | 202517005166-FORM-26 [19-04-2025(online)].pdf | 2025-04-19 |
| 11 | 202517005166-FORM 3 [05-07-2025(online)].pdf | 2025-07-05 |